Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
whistleblower
Pharma
Pfizer pays $60M to resolve Biohaven's Nurtec kickback claims
Pfizer—which bought Biohaven in 2022—is commiting more than $59.7 million to resolve kickback allegations tied to migraine med Nurtec.
Fraiser Kansteiner
Jan 27, 2025 10:39am
Whistleblower lawsuit claims GSK hid Zantac risks for decades
May 21, 2024 10:30am
Lilly's Branchburg production site in trouble with the FDA again
Jan 22, 2024 11:35am
Lilly moves to settle whistleblower lawsuit
Sep 29, 2023 11:35am
Pfizer defends against whistleblower suit from former manager
Aug 10, 2023 2:44pm
Lilly ordered to pay millions more in False Claims Act case
May 10, 2023 10:24am
